Stephen Balk

5.5k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

Stephen Balk is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Stephen Balk has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in Stephen Balk's work include Prostate Cancer Treatment and Research (6 papers), Hormonal and reproductive studies (3 papers) and Estrogen and related hormone effects (3 papers). Stephen Balk is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Hormonal and reproductive studies (3 papers) and Estrogen and related hormone effects (3 papers). Stephen Balk collaborates with scholars based in United States, Israel and Canada. Stephen Balk's co-authors include Stephen R. Plymate, Peter S. Nelson, Elahe A. Mostaghel, Bruce Montgomery, Robert L. Vessella, Alvin M. Matsumoto, Glenn J. Bubley, Brett T. Marck, Sabrina Rossi and Phillip G. Febbo and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Stephen Balk

8 papers receiving 987 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

2011 474 citations Elahe A. Mostaghel, Brett T. Marck et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Balk United States	6	720	458	436	295	196	8	1.0k
Marika J. Linja Finland	11	1.0k 1.4×	678 1.5×	402 0.9×	291 1.0×	401 2.0×	15	1.4k
Natasja F. Dits Netherlands	16	539 0.7×	575 1.3×	342 0.8×	208 0.7×	143 0.7×	21	1.0k
Mary Barrett United Kingdom	4	589 0.8×	327 0.7×	226 0.5×	275 0.9×	151 0.8×	7	923
Nicholas I. Simon United States	11	521 0.7×	240 0.5×	253 0.6×	178 0.6×	135 0.7×	31	720
Nikhil Babu Oommen United Kingdom	6	904 1.3×	255 0.6×	366 0.8×	383 1.3×	176 0.9×	7	1.1k
Yanfeng Qi United States	13	556 0.8×	406 0.9×	201 0.5×	188 0.6×	124 0.6×	15	798
Shihua Sun United States	13	1.1k 1.5×	732 1.6×	455 1.0×	478 1.6×	333 1.7×	20	1.5k
O. Harris Ford United States	12	1.3k 1.7×	876 1.9×	394 0.9×	582 2.0×	471 2.4×	16	1.8k
Alison Reid United Kingdom	13	746 1.0×	412 0.9×	400 0.9×	98 0.3×	92 0.5×	20	1.1k
Emilda Thompson United Kingdom	4	658 0.9×	178 0.4×	223 0.5×	292 1.0×	132 0.7×	7	766

Countries citing papers authored by Stephen Balk

Since Specialization

Citations

This map shows the geographic impact of Stephen Balk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Balk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Balk more than expected).

Fields of papers citing papers by Stephen Balk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Balk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Balk. The network helps show where Stephen Balk may publish in the future.

Co-authorship network of co-authors of Stephen Balk

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Balk. A scholar is included among the top collaborators of Stephen Balk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Balk. Stephen Balk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Nyquist, Michael D., Michael T. Schweizer, Stephen Balk, et al.. (2017). Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions. Cancers. 9(12). 166–166. 32 indexed citations

2.

Patnaik, Akash, Massimo Loda, Philip W. Kantoff, et al.. (2014). 708: A Phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant, metastatic prostate cancer. European Journal of Cancer. 50. S171–S171. 1 indexed citations

3.

Mostaghel, Elahe A., Brett T. Marck, Stephen R. Plymate, et al.. (2011). Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants. Clinical Cancer Research. 17(18). 5913–5925. 474 indexed citations breakdown →

4.

Taplin, Mary‐Ellen, Tomasz M. Beer, Michael A. Carducci, et al.. (2008). Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC). Journal of Clinical Oncology. 26(15_suppl). 5068–5068. 4 indexed citations

5.

Li, Haojie, Glenn J. Bubley, Stephen Balk, et al.. (2007). Hypoxia‐inducible factor‐1α (HIF‐1α) gene polymorphisms, circulating insulin‐like growth factor binding protein (IGFBP)‐3 levels and prostate cancer. The Prostate. 67(12). 1354–1361. 43 indexed citations

6.

Ko, Yong & Stephen Balk. (2004). Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers. Current Pharmaceutical Biotechnology. 5(5). 459–470. 31 indexed citations

7.

Rossi, Sabrina, Edgard Graner, Phillip G. Febbo, et al.. (2003). Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.. PubMed. 1(10). 707–15. 231 indexed citations

8.

Fenton, Mary Anne, Todd D. Shuster, Mary Ellen Taplin, et al.. (1997). Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.. PubMed. 3(8). 1383–8. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact